Evidence map›Paper›PMID 20663932›Full record

ArticleMolecular cancer therapeutics2010

Immune competency of a hairless mouse strain for improved preclinical studies in genetically engineered mice.

Beverly S Schaffer, Marcia H Grayson, Joy M Wortham, Courtney B Kubicek, Amanda T McCleish, Suresh I Prajapati, Laura D Nelon, Michelle M Brady, Inkyung Jung, Tohru Hosoyama and 7 more

Abstract read
In one paragraph

Article in Molecular cancer therapeutics, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Article
  2. Article
  3. Towards a standardized diabetic prolonged wound healing model in hairless SKH1 mice.Experimental biology and medicine (Maywood, N.J.) · 2026
    Article
  4. Fentanyl overdose: Temporal effects and prognostic factors in SKH1 mice.Basic & clinical pharmacology & toxicology · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Ovarian Accumulation of Nanoemulsions: Impact of Mice Age and Particle Size.International journal of molecular sciences · 2021
    Article
  14. Frontiers in immunology · 2021
    Article
  15. Article
  16. 3D-printed Wash Station with Integrated Anesthesia Delivery Manifold for High-throughput Depilation of Laboratory Mice.Journal of the American Association for Laboratory Animal Science : JAALAS · 2019
    Article
  17. Article
  18. Repeat application of microneedles does not alter skin appearance or barrier function and causes no measurable disturbance of serum biomarkers of infection, inflammation or immunity in mice in vivo.European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V · 2017
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Beverly S SchafferGreehey Children's Cancer Research Institute, University of Texas Health Science Center, San Antonio, Texas, USA.
Marcia H Grayson
Joy M Wortham
Courtney B Kubicek
Amanda T McCleish
Suresh I Prajapati
Laura D Nelon
Michelle M Brady
Inkyung Jung
Tohru Hosoyama
Leslea M Sarro
Martha A Hanes
Brian P Rubin
Joel E Michalek
Charles B Clifford
Anthony J Infante
Charles Keller

Funding

TISSUE CULTURE---COREP30CA054174 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Robin Jean Leach · 1991 to 2026
$59.1M
Therapeutic Targets in Alveolar RhabdomyosarcomaR01CA133229 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI KELLER, CHARLES · 2008 to 2012
$1.9M
NCI NIH HHS 5R01CA133229-02NCI NIH HHS P30 CA054174NCI NIH HHS R01 CA133229
6 · The paper itself

Abstract

Genetically engineered mouse models (GEMM) of cancer are of increasing value to preclinical therapeutics. Optical imaging is a cost-effective method of assessing deep-seated tumor growth in GEMMs whose tumors can be encoded to express luminescent or fluorescent reporters, although reporter signal attenuation would be improved if animals were fur-free. In this study, we sought to determine whether hereditable furlessness resulting from a hypomorphic mutation in the Hairless gene would or would not also affect immune competence. By assessing humoral and cellular immunity of the SKH1 mouse line bearing the hypomorphic Hairless mutation, we determined that blood counts, immunoglobulin levels, and CD4+ and CD8+ T cells were comparable between SKH1 and the C57Bl/6 strain. On examination of T-cell subsets, statistically significant differences in naïve T cells (1.7 versus 3.4 x 10(5) cells/spleen in SKH1 versus C57Bl/6, P = 0.008) and memory T cells (1.4 versus 0.13 x 10(6) cells/spleen in SKH1 versus C57Bl/6, P = 0.008) were detected. However, the numerical differences did not result in altered T-cell functional response to antigen rechallenge (keyhole limpet hemocyanin) in a lymph node cell in vitro proliferative assay. Furthermore, interbreeding the SKH1 mouse line to a rhabdomyosarcoma GEMM showed preserved antitumor responses of CD56+ natural killer cells and CD163+ macrophages, without any differences in tumor pathology. The fur-free GEMM was also especially amenable to multiplex optical imaging. Thus, SKH1 represents an immune competent, fur-free mouse strain that may be of use for interbreeding to other genetically engineered mouse models of cancer for improved preclinical studies.

Indexed as

Genetic EngineeringAlopeciaAnimalsBlood Cell CountDisease Models, AnimalDrug Evaluation, PreclinicalFemaleImaging, Three-DimensionalImmunity, CellularImmunity, HumoralImmunizationImmunocompetenceLymphocyte SubsetsMaleMiceMice, Hairless

Identifiers

PMID20663932
PMCPMC2921575

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.